Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): late toxicity results from a randomised, non-inferiority, phase 3 trial

Shafak Aluwini, Floris J. Pos, Erik C. Schimmel, P.P. van der Toorn, Hanja de Jager, Wendimagegn Alemayehu, Wilma D. Heemsbergen, Ben Heijmen, Luca Incrocci

The Lancet Oncology · 2016 · 313 citations · 37 references

DOIFull text

Open access

Concepts

References

37